Cargando…
The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study
Treatment with pembrolizumab, an anti-programmed cell death-1 (PDCD-1) monoclonal antibody for the treatment of non-small cell lung cancers (NSCLCs) requires prior immunohistochemical (IHC) analysis of the expression of the programmed death-ligand 1 (PD-L1) (also known as CD274 molecule) which is a...
Autores principales: | Verocq, Camille, Decaestecker, Christine, Rocq, Laureen, De Clercq, Sarah, Verrellen, Audrey, Mekinda, Zita, Ocak, Sebahat, Compère, Christophe, Stanciu-Pop, Claudia, Salmon, Isabelle, Remmelink, Myriam, D'Haene, Nicky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115063/ https://www.ncbi.nlm.nih.gov/pubmed/32269612 http://dx.doi.org/10.3892/ol.2020.11458 |
Ejemplares similares
-
First Case Report of a Uterine Angiolipoleiomyoma With KRAS and KIT Mutations
por: Verocq, Camille, et al.
Publicado: (2022) -
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
por: Remmelink, Myriam, et al.
Publicado: (2020) -
Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma
por: Rusu, Stefan, et al.
Publicado: (2021) -
Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma
por: Pasau, Thomas, et al.
Publicado: (2022) -
The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer
por: D’Haene, Nicky, et al.
Publicado: (2018)